Mercodia MPO ELISA
Catalog nr 10-1176-01
Description
Immunoassay for quantitative determination of human MPO (myeloperoxidase) in serum or plasma.
Advantages
Calibrated against a highly purified, fully validated, commercially available MPO preparation.
| Format | 1 x 96 wells | ||
| Sample | Serum, plasma | ||
| Sample volume | 25 μL | ||
| Assay range | 3,5 - 200 μg/L | ||
| Sensitivity | ≤ 3 μg/L | ||
| Incubation (min) | 60+60+15 | ||
References
-
van der Zwan, L, P,
Scheffer, P (2011)
Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavorable NOS substrate-to-inhibitor ratio - the Hoorn Study
Read abstract -
Ndrepepa, G,
Braun, S,
Schomig, A (2010)
Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease
Read abstract -
Rao, V,S,
Nagaraj, R (2011)
Association of Inflammatory and Oxidative Stress Markers with Metabolic Syndrome in Asian Indians in India
Read abstract
Search
Ask Mercodia for Quotation
Direction for Use (PDF)
Technotes
Tech note Instruction platereader.pdf Tech note MPO Performance.pdf TN34-0106 Instruction handwash.pdf
Posters
Poster MPO as a Biomarker.pdf Poster Risk Marker for Atherosclerosis.pdf
Product sheets
10-1176-01 MPO.pdf
MSDS
MPO ELISA MSDS Rev 121126.pdf
Movies
View large movie Enzyme immunoassay for quantification of insulin